Share Share on Facebook Share on Twitter Pinterest Email Cleo Diagnostics (COV:AU) has announced The Royal Women’s Hospital Joins CLEO Ovarian Cancer Trial Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Lode Gold Announces $350,000 Non-Brokered Financing December 24, 2024 Cannabis Market 2024 Year-End Review December 24, 2024 Completion of QSM Acquisition December 24, 2024